Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Eur J Med Res ; 25(1): 46, 2020 Oct 07.
Article de Anglais | MEDLINE | ID: mdl-33028394

RÉSUMÉ

BACKGROUND: Emerging evidence indicates that an elevated C-reactive protein-to-albumin ratio (CAR) may be associated with a poor prognosis in pancreatic ductal adenocarcinoma (PDAC). Further evidence showing that this ratio has significant prognostic value could contribute to current prediction models and clinical decision-making. METHODS: Data were analysed of consecutive patients who underwent curative pancreatic resection between 2013 and 2018 and were histologically diagnosed with PDAC. We investigated the relation between the ultimate preoperative CAR and overall survival. RESULTS: A total of 163 patients were analysed. Median overall survival was 18 months (IQR 9-36). Multivariate analysis demonstrated that a higher CAR (HR 1.745, P = 0.004), a higher age (HR 1.062, P < 0.001), male sex (HR 1.977, P = 0.001), poor differentiation grade (HR 2.812, P < 0.001), and positive para-aortic lymph node(s) (HR 4.489, P < 0.001) were associated with a lower overall survival. Furthermore, a CAR ≥ 0.2 was associated with decreased overall survival (16 vs. 26 months, P = 0.003). CONCLUSION: We demonstrated that an ultimate preoperative elevated CAR is an independent indicator of decreased overall survival after resection for PDAC. The preoperative CAR may be of additional value to the current prediction models.


Sujet(s)
Protéine C-réactive/analyse , Carcinome du canal pancréatique/sang , Tumeurs du pancréas/sang , Sérum-albumine humaine/analyse , Sujet âgé , Marqueurs biologiques tumoraux/sang , Carcinome du canal pancréatique/anatomopathologie , Carcinome du canal pancréatique/chirurgie , Femelle , Humains , Mâle , Adulte d'âge moyen , Pancréatectomie/effets indésirables , Pancréatectomie/statistiques et données numériques , Tumeurs du pancréas/anatomopathologie , Tumeurs du pancréas/chirurgie , Période préopératoire , Analyse de survie
2.
J Laparoendosc Adv Surg Tech A ; 30(5): 495-500, 2020 May.
Article de Anglais | MEDLINE | ID: mdl-31971863

RÉSUMÉ

Introduction: Minimally invasive techniques have been suggested to achieve enhanced recovery and improved outcome after pancreaticoduodenectomy (PD). This study describes our experience and a stepwise technical implementation of the laparoscopic pancreaticoduodenectomy (LPD) during early introduction in 2016. Methods: A team of three hepatopancreaticobiliary surgeons with extensive experience in open pancreaticoduodenectomy (OPD) and with advanced laparoscopic skills started a proctor-guided program with LPD. The first 20 carefully selected cases were prospectively reviewed and compared with a matched OPD cohort. Results: In 20 months, 20 minimally invasive PDs were performed. Reviewing the first 10 LPD cases, 7 patients (70%) had anastomosis-related complications, versus 16% in OPD (P = .001). After consulting an international LPD expert, the team switched to a hybrid technique consisting of LPD followed by open reconstruction through midline minilaparotomy (LPD-OR). In the following 10 cases of LPD-OR, no anastomosis-related complications did occur (P = .342 OPD versus LPD-OR). Conclusion: Safe introduction of new techniques in minimally invasive major abdominal surgery is imperative. Based on our single-center experience, LPD-OR may be safer in the earliest phase of the learning curve of minimally invasive PD, as part of a stepwise implementation toward the fully laparoscopic technique.


Sujet(s)
Désunion anastomotique/étiologie , Laparoscopie/méthodes , Duodénopancréatectomie/méthodes , Sujet âgé , Anastomose chirurgicale/effets indésirables , Femelle , Humains , Laparoscopie/effets indésirables , Laparoscopie/enseignement et éducation , Courbe d'apprentissage , Durée du séjour , Mâle , Pancréatectomie , Duodénopancréatectomie/effets indésirables , Duodénopancréatectomie/enseignement et éducation , Études rétrospectives
3.
Case Rep Gastroenterol ; 12(1): 194-201, 2018.
Article de Anglais | MEDLINE | ID: mdl-29805366

RÉSUMÉ

Signet ring cell carcinoma (SRCC) of the ampulla of Vater is an extremely rare tumor. Our case describes a 45-year-old female presenting with jaundice and pruritus. Computed tomography, endoscopy, and endoscopic retrograde cholangiopancreatography showed a tumor of the ampulla of Vater without distant metastasis. Histological biopsy confirmed a malignant tumor with SRCC characteristics and immunohistochemical staining revealed a mixed type profile (both intestinal and pancreatobiliary characteristics). A pylorus-preserving pancreatoduodenectomy was performed and the patient recovered without complications. Pathology results concluded a pT2N0 ampullary SRCC. SRCC of the ampulla of Vater is known to be highly malignant. After 13 months of follow-up, our patient showed no signs of recurrence.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...